Purchases and Sales Made in Q1 2023 in Cti Biopharma Corp (CTIC)
This table provides information about the institutional ownership of Cti Biopharma Corp (CTIC) during Q1 2023. The information is specifically focused on institutions that hold shares of CTI BIOPHARMA CORP.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
May 15, 2023
Q1 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-47.6K- 92.86% |
$200K - $286K
|
3.66K
$33.3K
|
|
May 15, 2023
Q1 2023
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-56.3K- 4.32% |
$236K - $338K
|
1.25M
$11.3M
|
|
May 15, 2023
Q1 2023
|
Nomura Holdings Inc
Tokyo, M0 |
SELL
|
- |
-81K- 48.6% |
$340K - $487K
|
85.6K
$779K
|
|
May 11, 2023
Q1 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-138K- 11.64% |
$580K - $830K
|
1.05M
$9.53M
|
|
Apr 13, 2023
Q1 2023
|
Allspring Global Investments Holdings, LLC
|
SELL
|
- |
-174K- 95.95% |
$733K - $1.05M
|
7.35K
$66.8K
|
|
May 04, 2023
Q1 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-221K- 29.19% |
$930K - $1.33M
|
537K
$4.88M
|
|
May 11, 2023
Q1 2023
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-335K- 22.77% |
$1.41M - $2.01M
|
1.14M
$10.3M
|
|
May 12, 2023
Q1 2023
|
Ubs Group Ag
|
SELL
|
- |
-523K- 56.51% |
$2.2M - $3.15M
|
403K
$3.66M
|
|
May 15, 2023
Q1 2023
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-1.76MClosed |
$7.38M - $10.6M
|
0
$0
|
|
May 11, 2023
Q1 2023
|
Sofinnova Investments, Inc.
Menlo Park, CA |
SELL
|
- |
-1.81M- 39.34% |
$7.61M - $10.9M
|
2.79M
$25.4M
|
|
May 15, 2023
Q1 2023
|
Lion Point Capital, LP
New York, NY |
SELL
|
- |
-3.1M- 83.75% |
$13M - $18.6M
|
602K
$5.47M
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-3.57M- 22.28% |
$15M - $21.4M
|
12.4M
$113M
|
|
May 15, 2023
Q1 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-3.9M- 81.81% |
$16.4M - $23.4M
|
866K
$7.87M
|